Gianina Thornton
Nurse Practitioner · Bridgeport, CTNPI 1124737887
Payments from drug & device makers
Across 158 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$841
- Novo Nordisk$644
- Lilly USA, LLC$380
- AbbVie$322
- Amgen$201
- Merck$182
- plus $981 from 19 others
What the payments were for
- Food & beverage$3,552100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 23 | $841 |
| Novo Nordisk | 29 | $644 |
| Lilly USA, LLC | 18 | $380 |
| AbbVie | 17 | $322 |
| Amgen | 7 | $201 |
| Merck | 12 | $182 |
| Exact Sciences | 8 | $137 |
| Novartis | 8 | $133 |
| Boehringer Ingelheim | 6 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $92 |
| Mylan Specialty L.p. | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 3 | $73 |
| Corcept Therapeutics | 2 | $55 |
| Boston Scientific | 1 | $47 |
| Almatica Pharma LLC | 2 | $42 |
| Pfizer | 2 | $36 |
| Eisai Inc. | 2 | $27 |
| Bayer | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| GSK | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,552 in reported general payments places this provider in the 90th percentile of 1,162 nurse practitioner providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 73 | $85,645 |
| MounjaroTirzepatide | 22 | $35,022 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 37 | $34,639 |
| JardianceEmpagliflozin | 18 | $31,014 |
| EliquisApixaban | 19 | $27,956 |
| Humalog Kwikpen U-200Insulin Lispro | 13 | $26,529 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $19,186 |
| RexultiBrexpiprazole | 11 | $16,276 |
| XareltoRivaroxaban | 16 | $15,125 |
| MyrbetriqMirabegron | 17 | $12,406 |
| Breo ElliptaFluticasone/Vilanterol | 18 | $9,088 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $8,054 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,276 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,390 |
| Mirtazapine | 38 | $1,670 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $644 | $85,64573 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $110 | $37,29031 claims |
| Lilly USA, LLCMounjaro | $380 | $35,02222 claims |
| AstraZenecaBreztri Aerosphere | $841 | $34,63937 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $14 | $28,27433 claims |
| PfizerEliquis | $36 | $27,95619 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $73 | $16,27611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,162 nurse practitioner providers in Connecticut.
Other nurse practitioner in Bridgeport
- Janice TavaresBridgeport$17K
- Jose LatorreBridgeport$13K
- Lindita VincaCheshire$427K
- Catherine MilnePlymouth$361K
- Michele NovellaDanbury$331K
- Tiffany RydzNewtown$49K
- Paul FidrychNorwich$23K
- Priscilla QuilterNorwich$21K
- Kimberly BoldonMiddletown$19K
- Emma RobinsonStamford$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.